Whole Person Care: Choosing an ADHD Treatment

Author(s):

Key Takeaways

Erin Crown stresses the importance of addressing comorbidities in ADHD treatment, including anxiety, substance use, and depression.
A personalized approach is crucial, requiring a thorough patient history to differentiate symptoms and tailor treatments.
Crown is a psychiatric physician assistant and owner of Oasis LifeCare and Future Options Research in State College, PA.
She is a principal investigator in clinical trials, highlighting her dedication to advancing psychiatric care through research.

When a patient has comorbidities like anxiety, substance use, and depression, how can you best select a treatment?

CONFERENCE REPORTER
Erin Crown, MHS, PA-C, Psych-CAQ, shared how she addresses comorbidities such as anxiety, substance use, and depression, when selecting treatment for attention-deficit/hyperactivity disorder (ADHD), at the Real Psychiatry conference.

"It's whole person care. Nothing is a one-size-fits-all regimen for anyone. We need to make sure we're getting a good history, teasing apart symptoms and disorders, and tailoring our treatments to our patients needs," said Crown.

Ms Crown is a psychiatric physician assistant in State College, PA. She is the owner and managing member of Oasis LifeCare, the owner of Future Options Research, and principal investigator in clinical trials.